(2E,5Z)-2,5-Undecadien-1-ol
Common Name: |
(2E,5Z)-2,5-Undecadien-1-ol |
IUPAC Name: |
(2E,5Z)-undeca-2,5-dien-1-ol |
Molecular Formula: |
C4H10OS |
SMILES: |
CCCCC/C=CC/C=C/CO |
Inchi: |
1S/C11H20O/c1-2-3-4-5-6-7-8-9-10-11-12/h6-7,9-10,12H,2-5,8,11H2,1H3/b7-6-,10-9+ |
Inchi Key: |
DIAHHRRJYUXCRL-IXWMQOLASA-N |
Cas No: |
91212-78-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
106.19 |
Mass (g/mol) |
168.151 |
Molar Refractivity |
30.43 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
1 |
Rings |
|
TPSA |
59.03 |
Hetero Atoms |
1 |
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
259.50 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
3.062 |
iLOGP |
1.53 |
XLOGP3 |
0.70 |
WLOGP |
0.69 |
MLOGP |
0.75 |
ESOL Log S |
-0.87 |
ESOL Solubility (mg/ml) |
14.2 |
ESOL Solubility (mol/l) |
0.134 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.52 |
Ali Solubility (mg/ml) |
3.23 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.22 |
Silicos-IT Solubility (mg/ml) |
64.3 |
Silicos-IT Solubility (mol/l) |
0.61 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.45 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.515 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.738 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
0 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |